Carmignac Gestion Lowers Stock Holdings in Globe Life Inc. $GL

Carmignac Gestion reduced its holdings in Globe Life Inc. (NYSE:GL) by 35.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 170,000 shares of the company’s stock after selling 95,000 shares during the period. Carmignac Gestion owned about 0.22% of Globe Life worth $23,659,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank purchased a new position in shares of Globe Life during the 4th quarter valued at approximately $155,617,000. Northwestern Mutual Wealth Management Co. increased its holdings in Globe Life by 34,786.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock worth $123,345,000 after acquiring an additional 879,391 shares in the last quarter. AQR Capital Management LLC increased its holdings in Globe Life by 98.6% in the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after acquiring an additional 696,548 shares in the last quarter. Balyasny Asset Management L.P. purchased a new stake in Globe Life in the 3rd quarter worth $80,925,000. Finally, Arrowstreet Capital Limited Partnership raised its position in Globe Life by 32.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock worth $200,734,000 after acquiring an additional 355,399 shares during the period. 81.61% of the stock is currently owned by hedge funds and other institutional investors.

Globe Life Trading Down 0.1%

Shares of GL opened at $182.14 on Monday. Globe Life Inc. has a 52-week low of $127.85 and a 52-week high of $191.55. The stock has a market cap of $14.14 billion, a PE ratio of 12.09 and a beta of 0.48. The firm’s fifty day moving average is $171.52 and its two-hundred day moving average is $154.34. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.73%. Globe Life’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter last year, the company earned $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Research analysts forecast that Globe Life Inc. will post 15.7 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Weiss Ratings lowered shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. TD Cowen upped their price target on shares of Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Wells Fargo & Company raised their price target on shares of Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Piper Sandler lifted their price objective on Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a report on Wednesday, July 15th. Finally, JPMorgan Chase & Co. boosted their price objective on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $191.67.

Insider Buying and Selling at Globe Life

In other Globe Life news, EVP Michael Clay Majors sold 37,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the transaction, the executive vice president directly owned 53,518 shares of the company’s stock, valued at $9,560,455.52. This trade represents a 40.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 21,000 shares of the business’s stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $180.06, for a total value of $3,781,260.00. Following the transaction, the chief financial officer owned 50,568 shares in the company, valued at approximately $9,105,274.08. This represents a 29.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 169,174 shares of company stock worth $28,553,849 in the last 90 days. 2.11% of the stock is currently owned by insiders.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.